EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Navigating the AI Transformation in Healthcare
Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration
Advisory Board
KNOWLEDGE BANK
-
Articles
How Predictive Maintenance Reduces Downtime in Pharma Plants
The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises
What is Clinical Drug Trials and what are the four phases of clinical trials
In a clinical trial actors admit specific interventions according to the exploration plan or protocol created by the investigators These interventions may be medical products similar as medicines or bias procedures or changes to actors geste similar as diet Clinical trials may compare a new medical approach to a standard bone thats formerly available to a placebo that contains
Understanding Pharmacodynamics: The Science behind Drug Action Mechanisms
In the complicated world of pharmacology pharmacodynamics is also a place that is a bridge between chemistry and physiology Drugs do something somewhere and this explains how they do it In a simple way pharmacodynamics studies the action of drugs the effects of drugs in terms of their biochemical and physiological effects and how the effects are generated
A Closer Look at Pharmacological Interventions: Treatment Overview
Pharmacological interventions are a cornerstone of modern healthcare encompassing a diverse array of medications designed to treat alleviate or prevent various medical conditions
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
The earliest example of in vivo expression of exogenous mRNA was by direct intramuscular injection in mice without the aid of a delivery vehicle This appears to defy what is known about nucleic acids being that they are large polar and metabolically unstable drugs that do not cross cell membranes However since cytoplasmic delivery is essential for mRNA transcription
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
Predicting unknown binding sites for transition-metal-based compounds in proteins
Transitionmetalbased compounds are promising therapeutic agents particularly in cancer treatment However predicting the binding sites of such compounds remains a major challenge In this work we investigate the applicabilit
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
What is Clinical Drug Trials and what are the four phases of clinical trials
James A Uchizono
A clinical study involves exploration using mortal levies( also called actors) that's intended to add to medical knowledge. There are two main types of clinical studies clinical trials( also calle...
-
2
Understanding Pharmacodynamics: The Science behind Drug Action Mechanisms
Kate Williamson
This article has examined the pharmacodynamics science, including drug action mechanisms, receptor theory, and determinants affecting drug efficacy and potency. It focuses on the importance of agonist...
-
3
A Closer Look at Pharmacological Interventions: Treatment Overview
Kate Williamson
This comprehensive overview explores the core aspects of pharmacological interventions in modern healthcare, covering mechanisms, classifications, and the impact on patient outcomes. Addressing challe...
-
4
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
Kate Williamson
The synergy of bioinformatics and computational biology revolutionizes genome analysis, decoding DNA sequences, gene expression patterns, protein structures, and evolutionary relationships. It empower...
-
5
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
Ruvanthi N. Kularatne
Rachael M. Crist
Stephan T. Stern
The earliest example of in vivo expression of exogenous mRNA is by direct intramuscular injection in mice without the aid of a delivery vehicle. The current state of the art for therapeutic nucleic ac...
press releases Read more...
Cytovance Biologics Expands Process Development Services with Perfusion Capabilities
Cytovance Biologics a leading USbased contract development and manufacturing organization CDMO serving the biopharmaceutical industry today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities
Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma
Anova Enterprises Inc Anova a technology enabled CRO dedicated to accelerating promising treatments today announced its partnership with Nouveau Biosciences Inc to conduct cancer focused
Gerresheimer Commissions Photovoltaic System in Pfreimd
Gerresheimer an innovative system and solution provider and a global partner for the pharma biotech and cosmetic industries has successfully commissioned a photovoltaic system at its Pfreimd site following
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Ligand Pharmaceuticals Incorporated Nasdaq LGND today announced it has completed its acquisition of XOMA Royalty Corporation XOMA Royalty a biotechnology royalty aggregator for per
Events Read more...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
LATEST NEWS Read more...
Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease
Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB
Kairos Pharma Reports Positive Interim Safety Results from Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma has reported positive interim safety results from its ongoing Phase clinical trial of ENV carotuximab in combination with osimertinib Tagrisso for patients with advanced EGFRmutated nonsmall cell lung cancer NSCLC
FDA Grants Priority Review to Roche’s Gazyva/Gazyvaro for Primary Membranous Nephropathy
Roche has announced that the US Food and Drug Administration FDA has granted Priority Review to its supplemental Biologics License Application sBLA for GazyvaGazyvaro obinutuzumab as a treatment
FDA Grants Fast Track Designation to SOTIO’s SOT109 for Advanced Colorectal Cancer
SOTIO Biotech has received Fast Track Designation FTD from the US Food and Drug Administration FDA for SOT its investigational antibodydrug conjugate ADC for the treatment of patients
Armata Pharmaceuticals Secures FDA Agreement on Initial Paediatric Study Plan for AP-SA02
Armata Pharmaceuticals has received agreement from the US Food and Drug Administration FDA on its Initial Paediatric Study Plan iPSP for APSA supporting the future evaluation of the investigational
DA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Disease Treatment
Eisai and Biogen have received approval from the US Food and Drug Administration FDA for a supplemental Biologics License Application sBLA for LEQEMBI IQLIK lecanemabirmb a onceweekly subcutaneous injection for the initiation treatment of early Alzheimers disease




